Reference to an earlier post by "hottod": "....but I guess there is the possibilty of a second Rett drug entering the market in approx. 3 years."
hottod/others: "hottod"/others: I just wonder if the advantage of being in the market 3 years before a competitor is not a kind of "wipe-out" for a company coming that much later? Unless, of course, that next Rett drug would show much better efficacy, of course....
Comments most welcome.
Wishing NEU holders a relaxing weekend ahead,
wasa
Acadia, page-537
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.75 |
Change
0.000(0.00%) |
Mkt cap ! $1.757B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1290 | $14.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.07 | 435 | 1 |
View Market Depth
| Last trade - 09.57am 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable